Trigemina CEO and leadership

David Yeomans is the director of pain research and a tenured associate professor of anesthesia at Stanford University School of Medicine. He is the chair of the scientific advisory board of three companies and an advisor to numerous pharmaceutical and biotech companies, as well as venture capital firms and intellectual property law practices. Dr. Yeomans has authored more than 90 peer reviewed articles and 11 book chapters in the field of pain, and has been the recipient of numerous NIH grants. He has authored numerous issued patents and patent applications and co-founded two companies devoted to the management of pain. Dr. Yeomans earned an AB degree from Dartmouth College, received his PhD in neuroscience from the University of Florida, and completed his research training as a NIH fellow at the University of Illinois.

Charles Yeomans is a President/CEO at Trigemina Inc and Principal Business Advisor at SiteOne Therapeutics Inc. He works or has worked as President/CEO at Health Benefits Coalition and President/CEO at Portal Group Holdings, Inc.. Charles studied at Stanford University.

Experienced Chief Financial Officer with a demonstrated history of working various industries including financial services, primarily insurance brokerage, biotech and information technology. Skilled in all aspects of being a CFO including financial management, securing capital and investor relations. In addition, extensive experience in operational management operations. Particular focus on working with early stage companies.

Dr. Shashidhar Kori has spent more than 30 years in the field of Neurosciences. Prior to joining ATI, Dr. Kori was VP of Clinical Development and Medical Affairs at Allergan and MAP Pharmaceuticals. Earlier in his industry career he was Senior Director, Clinical Development at GlaxoSmithKline. Under these leadership roles, Dr. Kori ran Clinical Operations including the execution of numerous clinical studies to support product development and commercialization, oversaw an active publication strategy, built a new Medical Affairs department and had significant involvement in new product development and discussions with global regulatory authorities. Prior to joining industry, Dr. Kori was in clinical practice and had a distinguished academic career at major universities across the United States including Founding Director of the Pain and Palliative Care Program at Duke University and Vice Chairman of Department of Neurology at USF College of Medicine. Dr. Kori has authored more than 90 publications and has given 150 national and international invited lectures on pain and headache management. Dr. Kori received his medical degree from Kasturba Medical College in Mangalore, India. He completed his residencies in Internal Medicine at the VA Medical Center in Brooklyn, NY and Neurology at St. Vincent’s Hospital and Medical Center in New York, NY. He served fellowships in Neuro-oncology, Neuroimmunology and Immunobiology and Cancer Pain at Memorial Sloan-Kettering Cancer Center, NY.

Professor Stephen D. Silberstein, MD, is Professor of Neurology and Director of the Jefferson Headache Center at Thomas Jefferson University, and a leading expert in migraine. He is a Fellow of the American College of Physicians, the American Academy of Neurology, The American Neurological Association, and the American Headache Society. He has served the American Headache Society as President, Treasurer, and Board of Directors member. He has served on the Publications, Scientific, and Education Committees of the American Headache Society and was Co-chairman of the Annual Scientific Meeting. He is current chair of the guidelines committee of the American Headache Society. Dr. Silberstein is an active member of the American Academy of Neurology and was Co-director of the national and international Headache Guideline Project, in cooperation with the Agency for Health Care Policy and Research. He was the Chairman of the International Headache Society meeting in Philadelphia in 2009. He was Chairman of the headache research group of the World Federation of Neurology. Dr. Silberstein received his medical degree from the University of Pennsylvania. He then completed a medical internship and junior residency at the Hospital of the University of Pennsylvania. After completing a fellowship in neurology at the National Hospital for Nervous Diseases in London, Dr. Silberstein served as a Pharmacology Research Associate in the Toxicology Laboratory of Clinical Science at the National Institutes of Mental Health, and completed a neurology residency at the Hospital of the University of Pennsylvania. Dr. Silberstein is the Senior Editor of the 8th edition of Wolff's Headache and Other Head Pain, Associate Editor of Cephalalgia and CNS Drugs, and a present or prior member of the Editorial Board of Headache; Cephalalgia; Acta Neurologica Scandinavica; Journal of Neurology, Neurosurgery & Psychiatry; and Topics in Pain Management. He is an ad hoc reviewer for many publications, including The New England Journal of Medicine; Brain, The Lancet, JAMA, Mayo Clinic Proceedings, Annals of Neurology, and Neurology. He has over 300 scientific publications.

David Yeomans is the director of pain research and a tenured associate professor of anesthesia at Stanford University School of Medicine. He is the chair of the scientific advisory board of three companies and an advisor to numerous pharmaceutical and biotech companies, as well as venture capital firms and intellectual property law practices. Dr. Yeomans has authored more than 90 peer reviewed articles and 11 book chapters in the field of pain, and has been the recipient of numerous NIH grants. He has authored numerous issued patents and patent applications and co-founded two companies devoted to the management of pain. Dr. Yeomans earned an AB degree from Dartmouth College, received his PhD in neuroscience from the University of Florida, and completed his research training as a NIH fellow at the University of Illinois.